We’re optimistic that the coronavirus vaccine being developed by MigVax can bring very, very good news to the world, as I told CBN. The company believes it can build off of the coronavirus vaccine they previously developed for poultry and adapt it for the human coronavirus. Hear more from me on the topic, on Israel’s Channel 13.


Professor Ferid Murad of Stanford University won the 1998 Nobel Prize for discovering the role of nitric oxide in the cardiovascular system. He says the nitric oxide treatment for coronavirus by SaNOtize that proved 99% effective in killing coronavirus in lab tests at Utah State University and was approved for clinical trials by Health Canada “could be effective in treating infections, including COVID-19”. Read my thoughts here.

Top Tech News

Coronavirus and sports: OurCrowd portfolio company PlaySight is instrumental in bringing back tennis

I told NoCamels, the crisis has accelerated digital tech trends at warp speed – Israeli VCs are cautiously optimistic about the future, despite pandemic

“We’re getting closer than ever to COVID-19 vaccine clinical trials, and it is all thanks to MigVax,” Hillel Fuld reports in The Jerusalem Post.

Energy efficiency company enVerid Systems raises $20M led by Breakthrough Energy Ventures with participation from Ajax Strategies, Building Ventures and OurCrowd.

Israeli digital microscopy company Scopio raises $16M; this OurCrowd portfolio company automates the imaging of full microscopy samples into uniquely high resolution digital scans.

Watch the Watchman Newscast, on how Israeli scientists and researchers are racing to create a vaccine and coming up with innovative strategies to fight COVID-19. 

Jon Watchman

Israel at 72: Coronavirus-fighting ingenuinty reinforces Israel as the “collaboration nation”. Also, see 72 Israeli companies fighting COVID-19, 11 of which are OurCrowd portfolio companies.

Watch the latest from OurCrowd

Meet the makers of Tyto Care, the remote device allowing quarantined coronavirus patients and their medical examiners to work together while lowering exposure – inside and outside hospitals. Watch this interview with CEO Dedi Gilad to understand why his device is safe and efficient for patients to use, even while distanced from their doctors.

tytocare tofl

Looking to connect

With open positions at our global portfolio companies, here are a few of the most exciting:

Search and filter through OurTalent to find your next challenge.